Skip to content
★ Sign in to follow
JC

James C. Lancaster Jr.

Orexigen Therapeutics, Inc.
Total declarations
20
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (18 ops.)
€60k

Latest filing published 28 Dec 2007 for Orexigen Therapeutics, Inc., €4,141.

Insider track record

Disclosed buys
0
Disclosed sells
18
Signal history

No signal scores available.

James C. Lancaster Jr.: trading record in brief

This profile gathers the share dealings of James C. Lancaster Jr. in Orexigen Therapeutics, Inc. In total, 20 filings cover trades dated from 26 November 2007 to 26 December 2007.

The open-market record consists of 18 sales worth €60k, with no purchase. Other entries cover 2 option exercises.

Most recently, on 28 December 2007, the filings show an option exercise worth €4,141 in Orexigen Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to James C. Lancaster Jr.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total

20 of 20 declarations